medigraphic.com
ISSN 1561-2988 (Print)

2011, Number 3

Next >>

Rev Cubana Farm 2011; 45 (3)

Ceftaroline and ceftobripol as new cephalosporines

Morejón GM

Language: Spanish
References: 10
Page: 318-320
PDF size: 91.49 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Morejón M, Cué M. Salup R. Actualización en antimicrobianos sistémicos. La Habana: Editorial Ciencias Medicas; 2005. p. 42.

  2. Boyce JM, Cookson B, Christiansen K, Hori S, Vuopio-Varkila J, Kocagöz S, et al. Methicillin-resistant Staphylococcus aureus. Lancet Infect Dis. 2005;5(10):653-63.

  3. Mohr JF, Murray BE. Point: Vancomycin Is Not Obsolete for the Treatment of Infection Caused by Methicillin-Resistant Staphylococcus aureus. Clin Infect Dis. 2007;44:1536-42.

  4. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st Century-A clinical super-challenge. N Engl J Med. 2009;360:439-43.

  5. Boucher HW, Sakoulas G. Perspectives on Daptomycin Resistance, with Emphasison Resistance in Staphylococcus aureus. Clin Infect Dis. 2007;45:601-8.

  6. Talbot GH, Thye D, Das A, Ge Y. Phase 2 Study of Ceftaroline versus Standard Therapy in Treatment of Complicated Skin and Skin Structure Infections. Antimicrob Agents Chemother. 2007;51:10:3612-6.

  7. Cruz ME, Sánchez EM. Cálculo de propiedades moleculares de cefalosporinas: cefradina, cefelxina, cefadroxilo, cefprozilo y ceftobiptole. MediSur [Internet]. 2010 Oct [citado 20 Feb 2011 ]; 8(5):17-25. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1727-897X2010000500005&script=sci_arttext

  8. Cédric J, Caillon J, Le Mabecque V, Miègeville AF, Hamel A, Bugnon D, et al. In vivo Efficacy of Ceftaroline (PPI-0903), a New Broad-Spectrum Cephalosporin, Compared with Linezolid and Vancomycin against Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus in a Rabbit Endocarditis Model. Antimicrob Agents Chemother. 2007;51(9):3397-400.

  9. Widmer AF. Ceftobiprole: A New Option for Treatment of Skinand Soft-Tissue Infections due to Methicillin-Resistant Staphylococcus aureus. Clin Infect Dis. 2008;46:656-8.

  10. Casellas JM. CA-MRSA: Qué son? Cómo diagnosticarlos? Cómo tratar sus infecciones? La Gaceta Infect Microb Clin. 2008;2(2);1-4.




2020     |     www.medigraphic.com